Aberrant methylation of tumor suppressor genes in head and neck squamous cell carcinoma: Is it clinically relevant?;La méthylation des gènes suppresseurs de tumeur dans les cancers des voies aérodigestives supérieures: Quelle signification clinique?

Bulletin du Cancer

Volumn 94, Issue 2, 2007, Pages 191-197

  Righini, Christian Adrien ^a,b   De Fraipont, Florence ^a,b   Reyt, Émile ^a   Favrot, Marie Christine ^a,b  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

Author keywords

Clinical applications; DNA methylation; Epigenetic; Head and neck squamous cell carcinoma

Indexed keywords

BISULFITE; DEATH ASSOCIATED PROTEIN KINASE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN P16; TISSUE INHIBITOR OF METALLOPROTEINASE 3; UVOMORULIN;

ALLELE; CANCER DIAGNOSIS; CANCER RESEARCH; CHROMOSOMAL LOCALIZATION; CPG ISLAND; DNA METHYLATION; DNA TRANSCRIPTION; EPIGENETICS; GENE DELETION; GENE INACTIVATION; GENETIC ANALYSIS; HEAD AND NECK CARCINOMA; HIGH RISK PATIENT; HUMAN; POLYMERASE CHAIN REACTION; PROGNOSIS; REVIEW; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; ARTICLE; CHROMOSOME ABERRATION; GENE SILENCING; GENETIC EPIGENESIS; GENETICS; LARYNX TUMOR; MOUTH TUMOR; OROPHARYNX TUMOR;

CHROMOSOME ABERRATIONS; DNA METHYLATION; EPIGENESIS, GENETIC; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HUMANS; LARYNGEAL NEOPLASMS; MOUTH NEOPLASMS; OROPHARYNGEAL NEOPLASMS;

EID: 33847719458     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2007.0202     Document Type: Review

References (36)

1. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002 ; 16 : 6-21.
2. Ehrlich M. DNA methylation in cancer : too much, but also too little. Oncogene 2002 ; 21 : 5400-13.
3. Feinberg AP, Gehrke CW, Kuo KC, Ehrlich M. Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res 1988 ; 48 : 1159-61.
4. Filion GJ, Defossez PA. Epigénétique et cancer. Bull Cancer 2006 ; 93 : 343-7.
5. Curtis CD, Goggins M. DNA methylation analysis in human cancer. Methods Mol Med 2005 ; 103 : 123-36.
6. Eads CA, Danenberg KD, Kawakami K, Saltz LB, Blake C, Shibata D, et al. MethyLight : a high-throughput assay to measure DNA methylation. Nucleic Acids Res 2000 ; 28 : E32.
7. Rosas SL, Koch W, da Costa Carvalho MG, Wu L, Califano J, Westra W, et al. Promoter hypermethylation pattetns of p16,06-methylguanine-DNA- methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res 2001 ; 61 : 939-42.
8. De Fraipont F, Moro-Sibilot D, Michelland S, Brambilla E, Brambilla C, Favrot MC. Promoter methylation of genes in bronchial lavages : a marker for early diagnosis of primary and relapsing non-small cell lung cancer? Lung Cancer 2005 ; 50 : 199-209.
9. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, et al. Genetic progression model for head and neck cancer : implications for field cancerization. Cancer Res 1996 ; 56 : 2488-92.
10. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JP, Davidson NE, et al. Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 1995 ; 55 : 4525-30.
11. Righini C, de Fraipont F, Timsit JF, Faure C, Brambilla E, Reyt E, et al. Tumor specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence. Clin Cancer Res 2007 ; (in press).
12. Maruya S, Issa JP, Weber RS, Rosenthal DI, Haviland JC, Lotan R, et al. Differential methylation status of tumor-associated genes in head and neck squamous carcinoma : incidence and potential implications. Clin Cancer Res 2004 ; 10 : 3825-30.
13. Shaw RJ, Liloglou T, Rogers SN, Brown JS, Vaughan ED, Lowe D, et al. Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer : quantitative evaluation using pyrosequencing. Br J Cancer 2006 ; 94 : 561-8.
14. Ogi K, Toyota M, Ohe-Toyota M, Tanaka N, Noguchi M, Sonoda T, et al. Aberrant methylation of multiple genes and clinicopathological features in oral squamous cell carcinoma. Clin Cancer Res 2002 ; 8 : 3164-71.
15. Viswanathan M, Tsuchida N, Shanmugam G. Promoter hypermethylation profile of rumor-associated genes p16, p15, hMLH1, MGMT and E-cadhetin in oral squamous cell carcinoma. Int J Cancer 2003 ; 105 : 41-6.
16. Kresty LA, Mallery SR, Knobloch TJ, Song H, Lloyd M, Casto BC, et al. Alterations of p16 (INK4a) and p14 (ARF) in patients with severe oral epithelial dysplasia. Cancer Res 2002 ; 62 : 5295-300.
17. Lopez M, Aguirre JM, Cuevas N, Anzola M, Videgain J, Aguirregaviria J, et al. Gene promoter hypermethylation in oral rinses of leukoplakia patients : a diagnostic and/or prognostic tool? Eur J Cancer 2003 ; 39 : 2306-9.
18. Kulkarni V, Saranath D. Concurrent hypermethylation of multiple regulatory genes in chewing tobacco associated oral squamous cell carcinomas and adjacent normal tissues. Oral Oncol 2004 ; 40 : 145-53.
19. Belinsky SA, Klinge DM, Dekker JD, Smith MW, Bocklage TJ, Gilliland FD, et al. Gene promorer methylation in plasma and sputum incteases with lung cancer risk. Clin Cancer Res 2005 ; 11 : 6505-11.
20. Sanchez-Cespedes M, Esteller M, Wu L, Nawroz-Danish H, Yoo GH, Koch WM, et al. Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res 2000 ; 60 : 892-5.
21. Wong TS, Man MW, Lam AK, Wei WI, Kwong YL, Yuen AP. The study of p16 and p15 gene methylation in head and neck squamous cell carcinoma and their quantitative evaluation in plasma by teal-time PCR. Eur J Cancer 2003 ; 39 : 1881-7.
22. Fan CY. Epigenetic alterations in head and neck cancer : prevalence, clinical significance, and implications. Curr Oncol Rep 2004 ; 6 : 152-61.
23. Goldenberg D, Harden S, Masayesva BG, Ha P, Benoit N, Westra WH, et al. Intraoperative molecular margin analysis in head and neck cancer. Arch Otolaryngol Head Neck Surg 2004 ; 130 : 39-44.
24. Hasegawa M, Nelson HH, Peters E, Ringstrom E, Posner M, Kelsey KT. Patterns of gene promoter methylation in squamous cell cancer of the head and neck. Oncogene 2002 ; 21 : 4231-6.
25. Nakahara Y, Shintani S, Mihara M, Ueyama Y, Matsumura T. High frequency of homozygous deletion and methylation of p16 (INK4A) gene in oral squamous cell carcinomas. Cancer Lett 2001 ; 163 : 221-8.
26. Yeh KT, Chang JG, Lin TH, Wang YF, Tien N, Chang JY, et al. Epigenetic changes of tumor supptessot genes, P15, P16, VHL and P53 in oral cancer. Oncol Rep 2003 ; 10 : 659-63.
27. Chang HW, Chow V, Lam KY, Wei WI, Yuen A. Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance. Cancer 2002 ; 94 : 386-92.
28. Nakayama S, Sasaki A, Mese H, Alcalde RE, Tsuji T, Matsumura T. The E-cadherin gene is silenced by CpG methylation in human oral squamous cell carcinomas. Int J Cancer 2001 ; 93 : 667-73.
29. Dong SM, Sun DI, Benoit NE, Kuzmin I, Lerman MI, Sidransky D. Epigenetic inactivation of RASSF1A in head and neck cancer. Clin Cancer Res 2003 ; 9 : 3635-40.
30. Ai L, Vo QN, Zuo C, Li L, Ling W, Suen JY, et al. Ataxia-telangiectasia-mutated (ATM) gene in head and neck squamous cell carcinoma : promoter hypermethylation with clinical correlation in 100 cases. Cancer Epidemiol Biomarkers Prev 2004 ; 13 : 150-6.
31. Chang KW, Kao SY, Tzeng RJ, Liu CJ, Cheng AJ, Yang SC, et al. Multiple moleculat alterations of FHIT in betel-associated oral carcinoma. J Pathol 2002 ; 196 : 300-6.
32. Gao S, Worm J, Guldberg P, Eiberg H, Krogdahl A, Sorensen JA, et al. Loss of heterozygosiry at 9q33 and hypetmethylation of the DBCCR1 gene in oral squamous cell catcinoma. Br J Cancer 2004 ; 91 : 760-4.
33. Gao S, Worm J, Guldberg P, Eiberg H, Krogdahl A, Liu CJ, et al. Genetic and epigenetic alterations of the blood group ABO gene in oral squamous cell carcinoma. Int J Cancer 2004 ; 109 : 230-7.
34. Tsou JA, Hagen JA, Carpenter CL, Laird-Offringa IA. DNA methylation analysis : a powerful new tool for lung cancer diagnosis. Oncogene 2002 ; 21 : 5450-61.
35. Chan EC, Lam SY, Tsang KW, Lam B, Ho JC, Fu KH, et al. Aberrant promoter methylation in Chinese patients with non-small cell lung cancer : patterns in primary tumors and potential diagnostic application in bronchoalevolar lavage. Clin Cancer Res 2002 ; 8 : 3741-6.
36. Topaloglu O, Hoque MO, Tokumaru Y, Lee J, Ratovitski E, Sidtansky D, et al. Detection of promoter hypermethylation of multiple genes in the tumor and bronchoalveolar lavage of patients with lung cancer. Clin Cancer Res 2004 ; 10 : 2284-8.